Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy
Normal ophthalmic findings except hypertensive retinopathy stage 2 and 3, ametropia \< 6 Dpt.
You may not be if
Any of the following will exclude a healthy subject from the study:
Symptoms of a clinically relevant illness in the 3 weeks before the first study day
Presence or history of a severe medical condition as judged by the clinical investigator
Presence or history of arterial hypertension
Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study (except oral contraceptive)
Blood donation during the previous three weeks
Presence of any abnormalities preventing reliable measurements in the study eye as judged by the investigator
Ametropia \>= 6 Dpt
Pregnancy, planned pregnancy or lactating
Any of the following will exclude a patient with hypertensive retinopathy from the study:
Participation in a clinical trial in the 3 weeks preceding the screening visit
Symptoms of a clinically relevant illness in the 3 weeks before the first study day
Presence or history of a severe medical condition as judged by the clinical investigator
Blood donation during the previous three weeks
Hypertensive retinopathy stage 4
Presence of any abnormalities preventing reliable measurements in the study eye as judged by the investigator
Ametropia \>= 6 Dpt
Pregnancy, planned pregnancy or lactating
Clareo Health | Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy
